Eli Lilly Stock Forecast
NYSE: LLYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:03 PM ET · Delayed 15 min
Pre-market: 1,169.50 -0.04%
LLY analyst consensus
Consensus (30 analysts)
buy
Avg. price target
$1,329.21+13.65%
- Strong buy 6
- Buy 19
- Hold 3
- Sell 1
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 30 Wall Street analysts covering Eli Lilly (2026-10-07), 25 rate the stock a buy or strong buy, 3 rate it a hold and 2 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $1,329.21, with a high estimate of $1,600.00 and a low estimate of $930.00. The average target implies upside of 13.6% from the current price of $1,169.60.
The spread between the highest and lowest targets is 72.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LLY.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 6 | 20% |
| Buy | 19 | 63% |
| Hold | 3 | 10% |
| Sell | 1 | 3% |
| Strong sell | 1 | 3% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $930.00 | -20.49% |
| Average target | $1,329.21 | +13.65% |
| High target | $1,600.00 | +36.80% |